Norway· NO-ID_DC531932-279F-4BEB-AD49-7F3246B55815

Teveten Comp

A eprosartan und diuretika product containing eprosartan mesilate + hydrochlorothiazide, registered in Norway by Viatris Healthcare Ltd.. The same ATC class is registered in 5 of our 19 countries.

ATC C09DA02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedTeveten CompATCC09DA02REGISTER NO.NO-ID_DC531932-279F-4…PACKS LISTED3CHECKEDOctober 2, 2026

Where it is registered

Eprosartan und diuretika is registered in 5 of 19 countries.

Countries holding a registration under ATC C09DA02 (eprosartan und diuretika), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 3 of them publish a price we can compare per daily dose

Eprosartan und diuretika · ATC C09DA02

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Eprosartan Mesilate + Hydrochlorothiazide
Manufacturer
Viatris Healthcare Ltd.
Country
Norway (NO)
ATC code
C09DA02
ATC class
Eprosartan und Diuretika
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_DC531932-279F-4BEB-AD49-7F3246B55815
  • no_varenummer
    099813
    98
    NOK 642
  • gtin
    5099151908391

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for eprosartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eprosartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Eprosartan und diuretika in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eprosartan und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Teveten Plus
  • Belgium · Teveten Plus
  • Germany · Eprosartan Comp. Ratiopharm, Teveten Plus Hct
  • Spain · Futuran Plus, Navixen Plus
  • Finland · Teveten Comp
  • Greece · Teveten Plus
  • Ireland · Teveten Plus
  • Luxembourg · Teveten Plus
  • Netherlands · Teveten Plus
  • Portugal · Teveten Plus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce498c9f-09bd-4f2e-8572-d53c48417b1b
GET /v1/drugs/ce498c9f-09bd-4f2e-8572-d53c48417b1b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Eprosartan og diuretika",
  "merkevare_id": "ID_DC531932-279F-4BEB-AD49-7F3246B55815",
  "name_form_strength": "Teveten Comp tab 600 mg/12,5 mg",
  "prescription_group": "C"
}

See everything about eprosartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.